Analyses of tumor-specific T cell dynamics and tumor immune contexture in microsatellite instability-high cancers in response to first-line therapy

被引：0

作者：

Eissmann, Moritz ^{[1
]}

Huber, Anne ^{[1
]}

Allam, Amr ^{[1
]}

Dijkstra, Christine ^{[1
]}

Ernst, Matthias ^{[1
]}

机构：

[1] Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

253

引用

页数：2

共 50 条

[21] Microsatellite-stable tumors with high tumor mutational burden in association with tumor response to immune checkpoint inhibitor therapy across solid tumors and correlation with specific oncogenic alterations
Nizamuddin, Imran
Doukas, Peter
de Viveiros, Pedro Antonio Hermida
Mi, Xinlei
Katam, Neelima
Chae, Young Kwang
Behdad, Amir
Wehbe, Firas Hazem
Mahalingam, Devalingam
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[22] Transgenic B7-H3 therapy induces tumor-specific immune response in human oral squamous cell cancer: an in vitro study
Yang, Hong Y.
Chu, Mei
Zheng, Li W.
Zwahlen, Roger A.
Luo, Juan
Zou, Duo H.
Sun, Shun T.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2008, 106 (05): : 721 - 728
[23] Analysis of T-cell immune response in renal cell carcinoma: Polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity
Angevin, E
Kremer, F
Gaudin, C
Hercend, T
Triebel, F
INTERNATIONAL JOURNAL OF CANCER, 1997, 72 (03) : 431 - 440
[24] Advanced non-small-cell lung cancer treated with first-line pembrolizumab plus chemotherapy: tumor response dynamics as a marker for survival
Nishino, Mizuki
Wang, Xinan
Ricciuti, Biagio
Tseng, Shu-Chi
Park, Hyesun
Alessi, Joao V.
Vaz, Victor R.
Hatabu, Hiroto
Lin, Xihong
Christiani, David C.
Awad, Mark M.
EUROPEAN RADIOLOGY, 2023, 33 (10) : 7284 - 7293
[25] Advanced non-small-cell lung cancer treated with first-line pembrolizumab plus chemotherapy: tumor response dynamics as a marker for survival
Mizuki Nishino
Xinan Wang
Biagio Ricciuti
Shu-Chi Tseng
Hyesun Park
Joao V. Alessi
Victor R. Vaz
Hiroto Hatabu
Xihong Lin
David C. Christiani
Mark M. Awad
European Radiology, 2023, 33 : 7284 - 7293
[26] Effect of self antigen specific CD4+T cell precursor frequency on the anti-tumor immune response: Implications for adoptive T cell therapy
Malandro, Nicole
Budhu, Sadna
Murphy, Judith
Rizzuto, Gabrielle
Houghton, Alan
Merghoub, Taha
Wolchok, Jedd
JOURNAL OF IMMUNOLOGY, 2013, 190
[27] HIGH THROUGHPUT SCREENING OF HPV-ANTIGEN PEPTIDES AND EXPANSION OF TUMOR-SPECIFIC T CELLS FOR ADOPTIVE CELL THERAPY OF HPV-ASSOCIATED MALIGNANCIES
Langan, David
Lemaster, Jourdain
Suarez, Lauren
Kunwar, Pratima
Kim, Sojung
Oelke, Mathias
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A106 - A106
[28] REGULATION OF IMMUNE-RESPONSES AGAINST THE SYNGENEIC ADJ-PC-5 PLASMACYTOMA IN BALB/C MICE .4. TUMOR-SPECIFIC T SUPPRESSOR CELLS, INDUCED AT EARLY STAGES OF TUMORIGENESIS, ACT ON THE INDUCTION-PHASE OF THE TUMOR-SPECIFIC CYTOTOXIC T-CELL RESPONSE
HAUBECK, HD
KOLSCH, E
IMMUNOBIOLOGY, 1986, 171 (4-5) : 357 - 365
[29] Response to first-line treatment and histology are associated with achieving complete remission after the first salvage high-dose chemotherapy in relapsing germ cell tumor patients
Flavio Gössi
Martin Spahn
Panagiotis Samaras
Jörg Beyer
Julian Schardt
Thomas Pabst
Bone Marrow Transplantation, 2018, 53 : 820 - 825
[30] Response to first-line treatment and histology are associated with achieving complete remission after the first salvage high-dose chemotherapy in relapsing germ cell tumor patients
Gossi, Flavio
Spahn, Martin
Samaras, Panagiotis
Beyer, Jorg
Schardt, Julian
Pabst, Thomas
BONE MARROW TRANSPLANTATION, 2018, 53 (07) : 820 - 825

← 1 2 3 4 5 →